Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Takeda Pharmaceutical Company Limited

Market Cap 7,801B 48.69B 42B 38.62B 36.35B 68.3B 4,595B 68.87B 458B 178B 2,255B 183B 179B P/E 2026
46.4x
P/E 2027 * 40.2x
Enterprise Value 11,741B 73.28B 63.21B 58.12B 54.7B 103B 6,915B 104B 689B 268B 3,394B 275B 269B EV / Sales 2026
1.14x
EV / Sales 2027 * 2.53x
Free-Float
99.25%
Yield 2026
3.53%
Yield 2027 * 4.14%
1 day+2.00%
1 week+0.08%
Current month-1.58%
1 month-4.04%
3 months-14.19%
6 months+12.31%
Current year+4.18%
1 week 4,938
Extreme 4938
5,158
1 month 4,710
Extreme 4710
5,362
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer 59 2015-03-31
Director of Finance/CFO 48 2024-03-31
Chief Tech/Sci/R&D Officer 47 2022-01-31
Director TitleAgeSince
Director/Board Member 59 2014-05-31
Director/Board Member 60 2015-05-31
Director/Board Member 74 2016-05-31
Date Insider Type Main position Quantity % Market Cap.
04-26Free

Chief Technology Officer

212,470 0.0134%
04-26Free

Chief Financial Officer

15,614 0.0010%
04-26Free

Executive/Senior Manager

27,740 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
+2.00%+0.08%+16.25%+8.67% 48.69B
-0.94%-2.14%+40.54%+148.38% 992B
-0.42%-1.80%+53.69%+42.60% 564B
-0.56%-1.65%+19.27%+59.57% 391B
+0.06%+0.68%+24.66%+16.53% 330B
+0.01%-0.59%+27.97%+15.90% 280B
+0.07%-0.21%+27.70%+33.49% 279B
-0.12%+0.99%-40.86%-47.29% 196B
-1.78%+1.16%+17.79%+48.77% 184B
-1.40%+3.27%+16.16%+59.08% 156B
Average -0.30%+0.11%+20.32%+38.57% 341.99B
Weighted average by Cap. -0.53%-0.52%+29.32%+65.21%

Financials

2026 2027 *
Net sales 4,531B 28.28B 24.4B 22.43B 21.11B 39.67B 2,669B 40.01B 266B 103B 1,310B 106B 104B 4,630B 28.9B 24.93B 22.92B 21.57B 40.54B 2,727B 40.88B 272B 106B 1,338B 108B 106B
Net income 174B 1.09B 939M 864M 813M 1.53B 103B 1.54B 10.23B 3.98B 50.43B 4.09B 4B 184B 1.15B 990M 910M 857M 1.61B 108B 1.62B 10.79B 4.2B 53.16B 4.31B 4.22B
Net Debt 3,940B 24.59B 21.21B 19.5B 18.36B 34.49B 2,320B 34.78B 231B 89.98B 1,139B 92.28B 90.31B 3,914B 24.43B 21.08B 19.38B 18.24B 34.27B 2,306B 34.56B 230B 89.4B 1,132B 91.69B 89.73B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,455
Date Price Change Volume
26-06-18 5,037.00 ¥ +2.00% 3,465,300
26-06-17 4,938.00 ¥ -1.63% 3,890,400
26-06-16 5,020.00 ¥ -1.34% 3,072,600
26-06-15 5,088.00 ¥ +0.12% 3,450,400
26-06-12 5,082.00 ¥ +0.97% 4,711,800
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
4,938.00JPY
Average target price
6,086.87JPY
Spread / Average Target
+23.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!